REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2019 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 15th, 2019 Company IndustryThis Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories hereto.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 15th, 2019 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 15th, 2019 Company Industry JurisdictionSet forth in the space provided below the state(s), if any, in the United States in which you maintained your residence during the past two years and the dates during which you resided in each state:
COOPERATION AGREEMENTCooperation Agreement • January 20th, 2023 • Hudson Executive Capital LP • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledJanuary 20th, 2023 Company Industry JurisdictionViewRay, Inc. (the “Company”) and Hudson Executive Capital LP, on behalf of itself, its affiliates and its affiliated funds (such affiliates and affiliated funds (which, for the avoidance of doubt, shall include HEC Management GP LLC and HEC Master Fund LP), together with Hudson Executive Capital LP, collectively, “Hudson”), have agreed to the terms contained in this Cooperation Agreement (this “Agreement”). This Agreement will take effect as of the date hereof (the “Effective Date”). For purposes of this Agreement, we refer to each of the Company and Hudson as a “Party” and, together, as the “Parties”.
JOINT FILING AGREEMENTJoint Filing Agreement • January 25th, 2017 • Hudson Executive Capital LP • Semiconductors & related devices
Contract Type FiledJanuary 25th, 2017 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows that such information is inaccurate.
LETTER AGREEMENTLetter Agreement • April 27th, 2020 • Hudson Executive Capital LP • Calculating & accounting machines (no electronic computers) • Pennsylvania
Contract Type FiledApril 27th, 2020 Company Industry JurisdictionUSA Technologies, Inc. (the “Company”), on the one hand, and Hudson Executive Capital LP (“HEC”), on behalf of itself, its affiliates and its affiliated funds (such affiliates and affiliated funds (which, for the avoidance of doubt and without limitation, shall include HEC Management GP LLC, HEC Master Fund LP and HEC SPV IV LP), together with HEC, collectively, the “HEC Group”), on the other hand, have mutually agreed to the terms contained in this letter agreement (this “Letter Agreement”). For purposes of this Letter Agreement, we refer to each of the Company and the HEC Group as a “Party” and, collectively, as the “Parties.”
COOPERATION AGREEMENTCooperation Agreement • March 11th, 2021 • Hudson Executive Capital LP • Insurance agents, brokers & service • Delaware
Contract Type FiledMarch 11th, 2021 Company Industry JurisdictioneHealth, Inc. (the “Company”), on the one hand, and Hudson Executive Capital LP, on behalf of itself, its affiliates and its affiliated funds (such affiliates and affiliated funds (which, for the avoidance of doubt, shall include HEC Management GP LLC and HEC Master Fund LP), together with Hudson Executive Capital LP, collectively, “Hudson”), on the other hand, have agreed to the terms contained in this Cooperation Agreement (this “Agreement”). This Agreement will take effect as of the date hereof (the “Effective Date”). For purposes of this Agreement, we refer to each of the Company and Hudson as a “Party” and, together, as the “Parties.”
Joint Filing AgreementJoint Filing Agreement • June 8th, 2021 • Hudson Executive Capital LP • Services-computer processing & data preparation
Contract Type FiledJune 8th, 2021 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
ROLLOVER AND CONTRIBUTION AGREEMENTRollover and Contribution Agreement • December 15th, 2020 • Hudson Executive Capital LP • Services-business services, nec • Delaware
Contract Type FiledDecember 15th, 2020 Company Industry JurisdictionROLLOVER AND CONTRIBUTION AGREEMENT (this “Agreement”), dated as of December 15, 2020, by and between Catalyst Holdings Limited, a private company incorporated in England and Wales (“Holdings”), and Hudson Executive Capital LP, a Delaware limited partnership (“Hudson Executive”), HEC Master Fund LP, a Cayman Islands exempted limited partnership (“HEC Master Fund”), and Hudson SPV I LP, a Delaware limited partnership (“HEC SPV I,” and, collectively with Hudson Executive and HEC Master Fund, and any individual partner, director or employee of the foregoing listed on Schedule 1 who is a shareholder of the Company in a personal capacity and elects to participate in the rollover, “Rollover Investor”), shareholders of Cardtronics plc, a public limited company incorporated in England and Wales (the “Company”).
JOINT FILING AGREEMENTJoint Filing Agreement • June 27th, 2016 • Hudson Executive Capital LP • Pharmaceutical preparations
Contract Type FiledJune 27th, 2016 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • December 19th, 2019 • Hudson Executive Capital LP • Services-misc health & allied services, nec
Contract Type FiledDecember 19th, 2019 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • October 18th, 2021 • Hudson Executive Capital LP • Laboratory analytical instruments
Contract Type FiledOctober 18th, 2021 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • January 15th, 2016 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus
Contract Type FiledJanuary 15th, 2016 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • February 19th, 2021 • Hudson Executive Capital LP • Insurance agents, brokers & service
Contract Type FiledFebruary 19th, 2021 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
COOPERATION AGREEMENTCooperation Agreement • March 9th, 2022 • Hudson Executive Capital LP • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledMarch 9th, 2022 Company Industry JurisdictionViewRay, Inc. (the “Company”) and Hudson Executive Capital LP, on behalf of itself, its affiliates and its affiliated funds (such affiliates and affiliated funds (which, for the avoidance of doubt, shall include HEC Management GP LLC and HEC Master Fund LP), together with Hudson Executive Capital LP, collectively, “Hudson”), have agreed to the terms contained in this Cooperation Agreement (this “Agreement”). This Agreement will take effect as of the date hereof (the “Effective Date”). For purposes of this Agreement, we refer to each of the Company and Hudson as a “Party” and, together, as the “Parties”.
Joint Filing AgreementJoint Filing Agreement • February 24th, 2020 • Hudson Executive Capital LP • Electromedical & electrotherapeutic apparatus
Contract Type FiledFebruary 24th, 2020 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Company named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2018 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 14th, 2018 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • March 20th, 2018 • Hudson Executive Capital LP • Surgical & medical instruments & apparatus
Contract Type FiledMarch 20th, 2018 Company IndustryThe undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned’s ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.